Literature DB >> 18982357

Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Mahmut Civilibal1, Salim Caliskan, Sebuh Kurugoglu, Cengiz Candan, Nur Canpolat, Lale Sever, Ozgur Kasapcopur, Nil Arisoy.   

Abstract

Coronary artery calcification (CAC) is common in adults with chronic kidney disease (CKD) and progresses with time. However, data are limited for younger patients. We have previously reported CAC in eight of 53 children with CKD. After 2 years, CAC evaluation was repeated in 48 patients. The median CAC score (CACS) increased from 101.3 (1473.6 +/- 1978.6, range 8.5-4332) to 1759.2 (2236.4 +/- 2463.3, range 0-5858) Agatston units (AU). When the individual changes in CACS were evaluated one by one, we showed a mild decrease in two patients on hemodialysis (HD) and in one transplant (Tx) recipient, a moderate increase in one patient on HD, one on peritoneal dialysis (PD) and one Tx recipient, and a large increase in one HD patient. Also, CAC disappeared in one HD patient. All patients with no calcification at baseline remained calcification-free at follow-up. To obtain the individual cumulative exposure, we calculated time-averaged mean values, using the laboratory values from the beginning of dialysis to the first and second multidetector spiral computed tomography (MDCT) scans (baseline and final values, respectively). Final CACS was positively related to final calcium-phosphorus (CaxP) product, while CAC progression was inversely associated with final serum albumin level. This report is the first study with the largest number and the youngest cohort to document the natural history of coronary calcification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982357     DOI: 10.1007/s00467-008-1038-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

1.  Natural history of vascular calcification in dialysis and transplant patients.

Authors:  Sharon M Moe; Kalisha D O'Neill; Martina Reslerova; Martina Resterova; Naomi Fineberg; Scott Persohn; Cristopher A Meyer
Journal:  Nephrol Dial Transplant       Date:  2004-07-13       Impact factor: 5.992

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

Authors:  Gérard M London; Alain P Guérin; Francis H Verbeke; Bruno Pannier; Pierre Boutouyrie; Sylvain J Marchais; Fabien Mëtivier
Journal:  J Am Soc Nephrol       Date:  2007-01-03       Impact factor: 10.121

4.  Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients.

Authors:  Alaattin Yildiz; Esat Memisoglu; Huseyin Oflaz; Halil Yazici; Hamdi Pusuroglu; Vakur Akkaya; Faruk Erzengin; Savas Tepe
Journal:  Nephrol Dial Transplant       Date:  2005-02-16       Impact factor: 5.992

Review 5.  Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.

Authors:  Wajeh Y Qunibi
Journal:  J Am Soc Nephrol       Date:  2005-11       Impact factor: 10.121

6.  Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Authors:  F Tentori; W C Hunt; C A Stidley; M R Rohrscheib; E J Bedrick; K B Meyer; H K Johnson; P G Zager
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

7.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 8.  Slowing the progression of vascular calcification in hemodialysis.

Authors:  Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

9.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.

Authors:  Mhairi K Sigrist; Maarten W Taal; Peter Bungay; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 8.237

10.  Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure.

Authors:  Jun Oh; Rainer Wunsch; Martin Turzer; Malte Bahner; Paolo Raggi; Uwe Querfeld; Otto Mehls; Franz Schaefer
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

View more
  21 in total

1.  Can dialysis modality influence cardiovascular outcome?

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

Review 2.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

3.  The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology.

Authors:  Uwe Querfeld; Ali Anarat; Aysun K Bayazit; Aysin S Bakkaloglu; Yelda Bilginer; Salim Caliskan; Mahmut Civilibal; Anke Doyon; Ali Duzova; Daniela Kracht; Mieczyslaw Litwin; Anette Melk; Sevgi Mir; Betül Sözeri; Rukshana Shroff; René Zeller; Elke Wühl; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 8.237

Review 4.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

Review 5.  Phosphate is a vascular toxin.

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-11-17       Impact factor: 3.714

Review 6.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

7.  Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Authors:  Andreas Pasch; Geoffrey A Block; Matthias Bachtler; Edward R Smith; Wilhelm Jahnen-Dechent; Spyridon Arampatzis; Glenn M Chertow; Patrick Parfrey; Xiaoye Ma; Juergen Floege
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 8.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

9.  Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients.

Authors:  Mengjing Wang; Haiming Li; Li You; Xiaoling Yu; Min Zhang; Ruijiang Zhu; Chuanming Hao; Zhijie Zhang; Jing Chen
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 10.  Phosphate binders in CKD: chalking out the differences.

Authors:  Lesley Rees; Rukshana C Shroff
Journal:  Pediatr Nephrol       Date:  2009-11-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.